Ltd's (Nasdaq: RDHL) Guy Goldberg pitches to investors at the Proactive One2One virtual conference.
The company is a specialty biopharmaceutical company focussed on gastrointestinal and infectious diseases.
They promote several GI drugs in the U.S with a robust late-stage development pipeline.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of RedHill Biopharma named herein, including the promotion by the Company of RedHill Biopharma in any Content on the Site, the Company receives...
FOR OUR FULL DISCLAIMER CLICK HERE